GlassScriptPhysician profile
Amy Bingaman
NPI 1750359147
$44,432.42
in general payments reported to CMS, 2019-2025
12 companies · $24K in 2025
The $24K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $467 · 2023: $2,058 · 2024: $17K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $37K · Travel and Lodging: $4,567 · Food and Beverage: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $37,000.00 |
| Travel and Lodging | $4,566.80 |
| Food and Beverage | $2,211.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $44,034.79 | 2021-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Hologic Sales and Service, LLC | $145.03 | 2021 | |
| Baxter Healthcare | $41.66 | 2022 | |
| Medtronic, INC. | $33.80 | 2022 | |
| Monaghan Medical Corporation | $28.24 | 2023 | Aerobika |
| Bayer Healthcare Pharmaceuticals INC. | $26.44 | 2022 | |
| Medicem INC. | $24.27 | 2022 | |
| Coopersurgical, INC. | $24.26 | 2025 | Paragard T 380a |
| Minerva Surgical, INC | $23.81 | 2022 | |
| Biogen, INC. | $18.21 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $16.94 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $14.97 | 2024 | Gardasil, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bingaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.